SymBiosis II is a venture capital fund managed by SymBiosis Capital Management, focusing on advancing biotherapeutics innovations for serious and life-threatening diseases. The fund invests in biotechnology, life sciences, and medical sectors, with a concentration on late-stage companies.
Focus Areas
Investment Types
Notable Investments
